RA CAPITAL MANAGEMENT, L.P.

PrivateCIK: 1346824
Location

BOSTON, MA

πŸ“‹ What this filing means

RA CAPITAL MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 71 equity positions with a total reported market value of $9.76B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

71
Positions
$9.76B
Total AUM (reported)
468.02M
Total Shares

Allocation by class

TOTAL AUM$9.76B71 positions
SH$9.76B100.0%

Portfolio Concentration

Top 337.4%4–1028.2%11–2520.8%Rest13.5%TOP 1065.6%0%100%
Top 3$3.65B37.4%
4–10$2.76B28.2%
11–25$2.03B20.8%
Rest$1.32B13.5%

Top 3 weight

37.4%

Top 10 weight

65.6%

Voting Authority Distribution

Total shares with voting rights: 468.02M

Sole

Full voting authority

468.02M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole71
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings71
Rows:

ASCENDIS PHARMA A/S - ADR

SOLE
SH
Shares10.28M
TypeSH
Market value$2.19B
22.46%
Sole
10.28M
Shared
0.00
None
0.00

CIDARA THERAPEUTICS INC

SOLE
SH
Shares3.37M
TypeSH
Market value$743.41M
7.62%
Sole
3.37M
Shared
0.00
None
0.00

RHYTHM PHARMACEUTICALS INC

SOLE
SH
Shares6.67M
TypeSH
Market value$713.62M
7.31%
Sole
6.67M
Shared
0.00
None
0.00

AVIDITY BIOSCIENCES INC

SOLE
SH
Shares8.64M
TypeSH
Market value$623.28M
6.39%
Sole
8.64M
Shared
0.00
None
0.00

VAXCYTE INC

SOLE
SH
Shares10.72M
TypeSH
Market value$494.83M
5.07%
Sole
10.72M
Shared
0.00
None
0.00

SIONNA THERAPEUTICS INC

SOLE
SH
Shares9.91M
TypeSH
Market value$407.49M
4.17%
Sole
9.91M
Shared
0.00
None
0.00

NEWAMSTERDAM PHARMA CO NV

SOLE
SH
Shares9.55M
TypeSH
Market value$335.02M
3.43%
Sole
9.55M
Shared
0.00
None
0.00

TYRA BIOSCIENCES INC

SOLE
SH
Shares12.20M
TypeSH
Market value$320.70M
3.29%
Sole
12.20M
Shared
0.00
None
0.00

WAVE LIFE SCIENCES LTD

SOLE
SH
Shares18.20M
TypeSH
Market value$309.45M
3.17%
Sole
18.20M
Shared
0.00
None
0.00

MINERALYS THERAPEUTICS INC

SOLE
SH
Shares7.32M
TypeSH
Market value$265.78M
2.72%
Sole
7.32M
Shared
0.00
None
0.00

EDGEWISE THERAPEUTICS INC

SOLE
SH
Shares10.43M
TypeSH
Market value$258.78M
2.65%
Sole
10.43M
Shared
0.00
None
0.00

SEPTERNA INC

SOLE
SH
Shares7M
TypeSH
Market value$195.04M
2.00%
Sole
7M
Shared
0.00
None
0.00

NUVALENT INC-A

SOLE
SH
Shares1.88M
TypeSH
Market value$189.11M
1.94%
Sole
1.88M
Shared
0.00
None
0.00

DISC MEDICINE INC

SOLE
SH
Shares1.98M
TypeSH
Market value$156.92M
1.61%
Sole
1.98M
Shared
0.00
None
0.00

JANUX THERAPEUTICS INC

SOLE
SH
Shares11.19M
TypeSH
Market value$154.42M
1.58%
Sole
11.19M
Shared
0.00
None
0.00

PEPGEN INC

SOLE
SH
Shares20.06M
TypeSH
Market value$130.62M
1.34%
Sole
20.06M
Shared
0.00
None
0.00

TAYSHA GENE THERAPIES INC

SOLE
SH
Shares23.56M
TypeSH
Market value$129.56M
1.33%
Sole
23.56M
Shared
0.00
None
0.00

ARS PHARMACEUTICALS INC

SOLE
SH
Shares10.86M
TypeSH
Market value$126.53M
1.30%
Sole
10.86M
Shared
0.00
None
0.00

BIOCRYST PHARMACEUTICALS INC

SOLE
SH
Shares15.83M
TypeSH
Market value$123.45M
1.26%
Sole
15.83M
Shared
0.00
None
0.00

BICARA THERAPEUTICS INC

SOLE
SH
Shares6.96M
TypeSH
Market value$117.07M
1.20%
Sole
6.96M
Shared
0.00
None
0.00

PRAXIS PRECISION MEDICINES I

SOLE
SH
Shares373.79K
TypeSH
Market value$110.17M
1.13%
Sole
373.79K
Shared
0.00
None
0.00

GH RESEARCH PLC

SOLE
SH
Shares7.68M
TypeSH
Market value$97.49M
1.00%
Sole
7.68M
Shared
0.00
None
0.00

GERON CORP

SOLE
SH
Shares63.77M
TypeSH
Market value$84.18M
0.86%
Sole
63.77M
Shared
0.00
None
0.00

ARCELLX INC

SOLE
SH
Shares1.27M
TypeSH
Market value$82.62M
0.85%
Sole
1.27M
Shared
0.00
None
0.00

CLIMB BIO INC

SOLE
SH
Shares11.29M
TypeSH
Market value$77.71M
0.80%
Sole
11.29M
Shared
0.00
None
0.00
Page 1 of 3
RA CAPITAL MANAGEMENT, L.P. 13F Holdings β€” 71 Positions | Finecho